These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38099489)

  • 1. Remodelling of cAMP dynamics within the SERCA2a microdomain in heart failure with preserved ejection fraction caused by obesity and type 2 diabetes.
    Lai P; Hille SS; Subramanian H; Wiegmann R; Roser P; Müller OJ; Nikolaev VO; De Jong KA
    Cardiovasc Res; 2024 Mar; 120(3):273-285. PubMed ID: 38099489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the Role of SERCA2a Microdomain Remodeling in Heart Failure Induced by Obesity and Type 2 Diabetes.
    Lai P; Nikolaev VO; De Jong KA
    J Cardiovasc Dev Dis; 2022 May; 9(5):. PubMed ID: 35621874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HNO enhances SERCA2a activity and cardiomyocyte function by promoting redox-dependent phospholamban oligomerization.
    Sivakumaran V; Stanley BA; Tocchetti CG; Ballin JD; Caceres V; Zhou L; Keceli G; Rainer PP; Lee DI; Huke S; Ziolo MT; Kranias EG; Toscano JP; Wilson GM; O'Rourke B; Kass DA; Mahaney JE; Paolocci N
    Antioxid Redox Signal; 2013 Oct; 19(11):1185-97. PubMed ID: 23919584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early calcium handling imbalance in pressure overload-induced heart failure with nearly normal left ventricular ejection fraction.
    Rouhana S; Farah C; Roy J; Finan A; Rodrigues de Araujo G; Bideaux P; Scheuermann V; Saliba Y; Reboul C; Cazorla O; Aimond F; Richard S; Thireau J; Fares N
    Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):230-242. PubMed ID: 30463691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholamban pentamerization increases sensitivity and dynamic range of cardiac relaxation.
    Funk F; Kronenbitter A; Hackert K; Oebbeke M; Klebe G; Barth M; Koch D; Schmitt JP
    Cardiovasc Res; 2023 Jul; 119(7):1568-1582. PubMed ID: 36869774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart failure leads to altered β2-adrenoceptor/cyclic adenosine monophosphate dynamics in the sarcolemmal phospholemman/Na,K ATPase microdomain.
    Bastug-Özel Z; Wright PT; Kraft AE; Pavlovic D; Howie J; Froese A; Fuller W; Gorelik J; Shattock MJ; Nikolaev VO
    Cardiovasc Res; 2019 Mar; 115(3):546-555. PubMed ID: 30165515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphodiesterase 4D regulates baseline sarcoplasmic reticulum Ca2+ release and cardiac contractility, independently of L-type Ca2+ current.
    Beca S; Helli PB; Simpson JA; Zhao D; Farman GP; Jones P; Tian X; Wilson LS; Ahmad F; Chen SRW; Movsesian MA; Manganiello V; Maurice DH; Conti M; Backx PH
    Circ Res; 2011 Oct; 109(9):1024-1030. PubMed ID: 21903937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antiapoptotic protein HAX-1 mediates half of phospholamban's inhibitory activity on calcium cycling and contractility in the heart.
    Bidwell PA; Haghighi K; Kranias EG
    J Biol Chem; 2018 Jan; 293(1):359-367. PubMed ID: 29150445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel human R25C-phospholamban mutation is associated with super-inhibition of calcium cycling and ventricular arrhythmia.
    Liu GS; Morales A; Vafiadaki E; Lam CK; Cai WF; Haghighi K; Adly G; Hershberger RE; Kranias EG
    Cardiovasc Res; 2015 Jul; 107(1):164-74. PubMed ID: 25852082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of phospholamban function can exhibit cardiotoxic effects independent of excessive sarcoplasmic reticulum Ca2+-ATPase inhibition.
    Schmitt JP; Ahmad F; Lorenz K; Hein L; Schulz S; Asahi M; Maclennan DH; Seidman CE; Seidman JG; Lohse MJ
    Circulation; 2009 Jan; 119(3):436-44. PubMed ID: 19139388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac-specific overexpression of sarcolipin inhibits sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA2a) activity and impairs cardiac function in mice.
    Asahi M; Otsu K; Nakayama H; Hikoso S; Takeda T; Gramolini AO; Trivieri MG; Oudit GY; Morita T; Kusakari Y; Hirano S; Hongo K; Hirotani S; Yamaguchi O; Peterson A; Backx PH; Kurihara S; Hori M; MacLennan DH
    Proc Natl Acad Sci U S A; 2004 Jun; 101(25):9199-204. PubMed ID: 15201433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-tubule remodelling disturbs localized β2-adrenergic signalling in rat ventricular myocytes during the progression of heart failure.
    Schobesberger S; Wright P; Tokar S; Bhargava A; Mansfield C; Glukhov AV; Poulet C; Buzuk A; Monszpart A; Sikkel M; Harding SE; Nikolaev VO; Lyon AR; Gorelik J
    Cardiovasc Res; 2017 Jun; 113(7):770-782. PubMed ID: 28505272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased sarcoplasmic/endoplasmic reticulum calcium ATPase 2a activity underlies the mechanism of the positive inotropic effect of ivabradine.
    Xie M; Huang HL; Zhang WH; Gao L; Wang YW; Zhu XJ; Li W; Chen KS; Boutjdir M; Chen L
    Exp Physiol; 2020 Mar; 105(3):477-488. PubMed ID: 31912915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced sarcoplasmic reticulum Ca2+ -ATPase activity and dephosphorylated phospholamban contribute to contractile dysfunction in human hibernating myocardium.
    Nef HM; Möllmann H; Skwara W; Bölck B; Schwinger RH; Hamm Ch; Kostin S; Schaper J; Elsässer A
    Mol Cell Biochem; 2006 Jan; 282(1-2):53-63. PubMed ID: 16317512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New N-aryl-N-alkyl-thiophene-2-carboxamide compound enhances intracellular Ca
    Nikolaienko R; Bovo E; Yuen SL; Treinen LM; Berg K; Aldrich CC; Thomas DD; Cornea RL; Zima AV
    Biophys J; 2023 Jan; 122(2):386-396. PubMed ID: 36463408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the PLN p.Arg14del Mutation in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Badone B; Ronchi C; Lodola F; Knaust AE; Hansen A; Eschenhagen T; Zaza A
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ZBTB20 Regulates SERCA2a Activity and Myocardial Contractility Through Phospholamban.
    Ren AJ; Wei C; Liu YJ; Liu M; Wang P; Fan J; Wang K; Zhang S; Qin Z; Ren QX; Zheng Y; Chen YX; Xie Z; Gao L; Zhu Y; Zhang Y; Yang HT; Zhang WJ
    Circ Res; 2024 Feb; 134(3):252-265. PubMed ID: 38166470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pyridone derivative activates SERCA2a by attenuating the inhibitory effect of phospholamban.
    Kaneko M; Yamamoto H; Sakai H; Kamada Y; Tanaka T; Fujiwara S; Yamamoto S; Takahagi H; Igawa H; Kasai S; Noda M; Inui M; Nishimoto T
    Eur J Pharmacol; 2017 Nov; 814():1-8. PubMed ID: 28734932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose lithium feeding increases the SERCA2a-to-phospholamban ratio, improving SERCA function in murine left ventricles.
    Hamstra SI; Kurgan N; Baranowski RW; Qiu L; Watson CJF; Messner HN; MacPherson REK; MacNeil AJ; Roy BD; Fajardo VA
    Exp Physiol; 2020 Apr; 105(4):666-675. PubMed ID: 32087034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early consequences of the phospholamban mutation PLN-R14del
    Maniezzi C; Eskandr M; Florindi C; Ferrandi M; Barassi P; Sacco E; Pasquale V; Maione AS; Pompilio G; Teixeira VON; de Boer RA; Silljé HHW; Lodola F; Zaza A
    Acta Physiol (Oxf); 2024 Mar; 240(3):e14082. PubMed ID: 38214033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.